Company intelligence
Prescient
See further, go deeper, Deliver impact.
About Prescient
Prescient is the strategy-to-impact partner for life sciences companies. We help clients cut through complexity, build connected strategies, and turn stronger decisions into measurable business impact across the lifecycle. Bringing together deep expertise across Commercial, Competitive Strategy, Medical Affairs, and Value, Pricing & Access, Prescient combines scientific, market and stakeholder perspectives to help clients see further, go deeper and deliver impact where it counts. Prescient has been a portfolio company of Bridgepoint Development Capital since 2021 and Baird Capital since 2017. For more information, please visit: www.prescienthg.com.
Verified activity
Signals from Prescient
6 published signals
Presence & Recognition
Prescient is hosting a multi-stakeholder discussion on advancing equitable access to cancer care at UICC’s World Cancer Congress, moderated by Senior Principal Dr. Amanda Whittal.
Reported by Prescient
Presence & Recognition
Prescient is hosting a conversation on advancing equitable access to cancer care on September 24th, featuring a white paper exploring key issues ahead of the discussion.
Reported by Isabelle Laurence
Research & Knowledge
Prescient developed the Prescient Brand Plan Impact Index to give senior leaders a portfolio-level review of multiple brand plans at once.
Reported by Prescient
Research & Knowledge
Prescient released the Disease Area Strategy Impact Index to provide senior pharma leaders with an independent perspective to strengthen strategy, improve decision making, and identify opportunities to deliver industry best practice across their portfolio.
Reported by Prescient
Products & Services
Prescient shared innovative services to help biopharma leaders create a cohesive disease strategy encompassing multiple assets at different stages of the lifecycle with strategic pull through to execution.
Reported by Stephanie Hall
Presence & Recognition
Prescient is attending Fierce Life Sciences Events Pharma CI USA to discuss competitive intelligence for China and global CI teams.
Reported by Prescient